Samrat Pharmachem has informed that it enclosed compliance certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2022, received from Link Intime India.
The above information is a part of company’s filings submitted to BSE.